Investor · London, United Kingdom

Ray Prudo

Open Ray in the network graph →

Filings

11

SEC Form D

Connections

95

co-filers

Capital

$34.7M

across filings

Active

Aug 2014

to Sep 2022

Most-connected co-filers (95)

Peter Feldschreiber · London, United Kingdom8 shared Stuart Ungar · London, United Kingdom7 shared Clive Richardson · London, United Kingdom6 shared Michael Grissinger · London, United Kingdom5 shared James Hill · London, United Kingdom4 shared John B. Riley · HOUSTON, TX3 shared Aike Ho · Oakland, CA3 shared Joshua Aviv · Somerville, MA3 shared Mariel A. Joliet · HOUSTON, TX3 shared Jeffrey Zhao · West Hollywood, CA3 shared Jeffrey O'Donohue · SANTA MONICA, CA3 shared Christopher E. Nelson · New York, NY3 shared Zaid Ashai · Boston, MA3 shared Michael J. O'Neil · HOUSTON, TX3 shared George E. Marucci, Jr · HOUSTON, TX3 shared Colleen A. Meade · New York, NY3 shared Jared Walker · MERIDIAN, ID3 shared Tiger Legatus Capital Management, LLC · New York, NY3 shared Sara Y. Huda · Luxembourg, Luxembourg3 shared Bruce F. Heitler · Denver, CO3 shared David Byrne · London, United Kingdom3 shared Donald Williams · London, United Kingdom3 shared Eric Wiesen · San Francisco, CA3 shared Douglas L. Goodwillie · HOUSTON, TX3 shared

Recent filings (11)

Akari Therapeutics PlcOct 2025 · 15 co-filers$6.3M Akari Therapeutics PlcOct 2025 · 15 co-filers$6.3M Akari Therapeutics PlcSep 2022 · 25 co-filers$12.8M Akari Therapeutics PlcJul 2021 · 23 co-filers$12.3M ViaCyte Inc.Apr 2021 · 42 co-filers$58.5M Akari Therapeutics PlcMar 2020 · 23 co-filers$9.6M SIP Congruent Co-Investment Fund I, LPJul 2019 · 4 co-filers$500K 2040 Congruent Co-Investment Fund I, LPJul 2019 · 4 co-filers$500K ViaCyte Inc.Dec 2018 · 32 co-filers$90.0M Shell Congruent Co-Investment Fund I, LPDec 2018 · 7 co-filers$4.0M Akari Therapeutics PlcSep 2015 · 15 co-filers$75.0M Akari Therapeutics PlcSep 2015 · 15 co-filers$75.0M ViaCyte Inc.Aug 2014 · 24 co-filers$15.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Ray in the interactive graph →